IDEXX beats expectations on Q2 earnings, but cuts full-year outlook further

IDEXX Laboratories Inc. (Nasdaq: IDXX) on Tuesday posted second-quarter results that exceeded market expectations while again cutting its full-year financial outlook, citing macroeconomic risks and other headwinds.

The Westbrook-based provider of veterinary diagnostics, veterinary practice software and water testing reported Q2 earnings of $1.56 per share, beating the $1.54 per share consensus estimate of analysts polled by Zacks Investment Research. That compares to earnings per share of $2.34 a year ago. Read more

Related Posts

Business Leaders: Deborah Bronk steers Bigelow Lab expansion to boost reach, programming

Deborah Bronk is president, CEO and a senior research scientist at Bigelow Laboratory for Ocean Sciences in East Boothbay, which will...

24 March 2025

UNE retains R2 Research status, reinforcing leadership in scientific advancement

The University of New England has retained its status as one of the country’s leading research universities with the recent release...

23 March 2025

Maine college students investigate health effects of forever chemicals

Two dozen Maine college students are investigating the public health effects of forever chemicals by using zebrafish as human stand-ins and...

21 March 2025